Spirometer flow sensor market seen reaching $1.55 billion by 2030

The global spirometer flow sensor market is projected to grow from $1 billion in 2025 to $1.55 billion by 2030, driven by rising respiratory disease rates, healthcare spending and demand for remote monitoring. North America leads today, while Asia-Pacific is expected to grow fastest as telemedicine, home care and connected diagnostics expand.

Why it matters: - Spirometer flow sensors are becoming more important as healthcare systems expand respiratory monitoring and early disease detection. - Rising chronic lung disease, telemedicine and home care demand are pushing more use of connected diagnostic tools. - The market’s projected jump to $1.55 billion by 2030 signals continued spending on respiratory diagnostics and digital health infrastructure.

What happened: - The Business Research Company published a market outlook for spirometer flow sensors on July 22, 2026. - The report estimates the market will grow from $1 billion in 2025 to $1.09 billion in 2026. - The report forecasts the market will reach $1.55 billion by 2030. - The forecast implies an 8.8% CAGR from 2025 to 2026 and a 9.1% CAGR through 2030. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - More information is available in the full report.

The details: - A spirometer flow sensor measures the volume and speed of air inhaled and exhaled. - The sensor detects airflow changes and converts them into electrical signals for respiratory analysis. - The report points to chronic respiratory illness, hospital pulmonary function tests, early lung disease detection, diagnostic lab expansion and basic digital spirometry as historical growth drivers. - The report points to remote respiratory monitoring, home healthcare, telemedicine, AI-enhanced diagnostic precision, preventive screening and connected medical devices as forecast growth drivers. - Leading trends include AI-powered respiratory diagnostics, IoT-enabled spirometer sensors, cloud-based pulmonary function testing platforms, portable and handheld home-use devices and higher demand for high-accuracy digital airflow measurement tools. - The report identifies increasing respiratory disease prevalence as a major driver of demand. - Air pollution exposure is contributing to more respiratory illness through fine particulate matter, vehicle emissions and industrial smoke. - The UK Health Security Agency reported a 13% rise in tuberculosis cases in England in 2024, to 5,480 cases from 4,850 in 2023. - UK healthcare expenditure rose 6.5% in nominal terms and 2.4% in real terms from 2023 to 2024, according to the Office for National Statistics. - Government-funded healthcare spending in the UK reached $328 billion (£258 billion) in 2024, a 2.5% real-term increase from the prior year.

Between the lines: - The market outlook suggests respiratory diagnostics are shifting from clinic-centered testing toward continuous and at-home monitoring. - AI, cloud software and IoT features are moving from add-ons to core product expectations in this category. - Growth in healthcare spending gives hospitals and health systems more room to buy higher-cost diagnostic equipment. - The regional split points to a mature market in North America and a faster buildout phase in Asia-Pacific.

What's next: - Demand is likely to rise as more health systems adopt remote monitoring and preventive screening programs. - Device makers are expected to keep pushing portable, connected and higher-accuracy spirometer products. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics and updated graphics and tables. - The Business Research Company also highlights its broader research footprint across 30,000+ reports, 27 industries and 60+ geographies.

The bottom line: - Spirometer flow sensors are moving from niche respiratory tools to a bigger digital diagnostics market powered by chronic disease management, remote care and connected medical devices.